We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Gut Microbiome Analysis Identifies Frailty-Related Signatures in Older Adults

By LabMedica International staff writers
Posted on 14 Jul 2026

Frailty in older adults is marked by increased vulnerability to disease, falls, functional decline, and death, yet its biological drivers remain incompletely understood. More...

Because the gut microbiota influences multiple aspects of health and aging, investigators examined whether microbial composition and function reflect frailty status in late life. New findings show that reduced gut microbial diversity and functional capacity are associated with higher levels of frailty.

At the University of Gothenburg’s Sahlgrenska Academy, the team analyzed genetic material from the gut microbiota while assessing frailty with an internally developed and validated Frailty Mortality Index (FMI). The index integrates functional, physiological, and psychological dimensions associated with frailty and mortality risk. Microbial features evaluated included overall diversity, microbial gene counts, and predicted functional capacity.

The work draws on the Swedish SUPERB cohort of 2,081 community-dwelling women aged 75–80, and it is published in Nature Communications. Findings were examined for generalizability using an independent Chinese cohort of 1,448 older adults. The study analyzed gut microbiota profiles in relation to FMI and frailty-related clinical outcomes.

Higher FMI, indicating greater frailty and mortality risk, was associated with lower gut microbial diversity, fewer microbial genes, and reduced predicted functional capacity. These microbiome features were also linked to physical function, mortality, and fall-related injuries. The researchers identified 404 bacterial species significantly associated with FMI, many of which were replicated in the Chinese cohort, suggesting shared microbial signatures across settings.

According to the investigators, these results may help illuminate biological processes involved in frailty and aging. In the longer term, the knowledge could support approaches to identify older individuals at increased risk of adverse outcomes. The team emphasized that the work demonstrates associations rather than causation and that additional research is needed to determine whether gut microbiota changes contribute to frailty development or could be leveraged for preventive strategies.

“Our results show that the gut microbiota reflects key aspects of frailty in older adults. It is particularly interesting that several of the associations were replicated in an independent cohort from China, which reinforces the relevance of the findings,” said Marina Vilar Geraldi, a researcher at Sahlgrenska Academy, University of Gothenburg.

“Frailty is a complex condition, and our findings suggest that the gut microbiota may be an important part of the overall picture. The next step is to investigate whether these microbial patterns can aid in risk assessment or form the basis for future interventions,” said Mattias Lorentzon, Professor at the University of Gothenburg and Senior Consultant at Sahlgrenska University Hospital.

Related Links
Sahlgrenska Academy, University of Gothenburg


Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image:Schematic illustration of plasmonic microarray–based KRAS mutation detection from colorectal cancer patients. (Lee, J.Y., Mun, C.W., Kim, E.R. et al. npj Precision Oncology, 2026. https://doi.org/10.1038/s41698-026-01452-8)

Blood and Urine Liquid Biopsy Detects Early Colorectal Cancer Mutations

Early-stage colorectal cancer is difficult to assess noninvasively because tumor-derived mutations occur at extremely low levels in blood and urine, straining the sensitivity, cost, and turnaround time... Read more

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.